Octave Bioscience: A New Paradigm of Care

Doug Biehn, CEO of Octave Bioscience, sits down with Nasdaq's Head of Listings Operations, Leigh Hixon, to discuss how the company delivers comprehensive insights that brings scientific clarity to MS, enabling an optimal care journey for patients to live more harmonious lives.